D. E. Shaw & Co »

Ptc Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Ptc Therapeutics shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Ptc Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $30M 33M 0.92
2023-09-30 $24M 30M 0.80
2023-06-30 $31M 30M 1.03
2023-03-31 $26M 23M 1.14

More positions owned by D. E. Shaw & Co

Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
Booking Holdings (BKNG)
Netflix Put Option (NFLX)
Advanced Micro Devices Put Option (AMD)
Chipotle Mexican Grill (CMG)
Tesla Motors (TSLA)
Uber Technologies Put Option (UBER)
Exxon Mobil Corporation Put Option (XOM)
Citigroup Com New (C)
Alphabet Cap Stk Cl A (GOOGL)
Royal Caribbean Cruises Put Option (RCL)

View all positions for D. E. Shaw & Co

Top funds holding Ptc Therapeutics

Franklin Resources
Steelhead Partners
D. E. Shaw & Co
Wolverine Asset Management
DeepCurrents Investment Group
Whitebox Advisors
Readystate Asset Management
Kornitzer Capital Management
CSS
Context Capital Management

View all funds holding Ptc Therapeutics